SCHEMBL3420955

SCHEMBL3420955

CCCCNC(=O)OCC(COC(=O)NC)(COC(=O)NC)COC(=O)NC

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 14/20 0.59
▸ EPHX1 P07099 2/20 0.49
▸ ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18417569 0.89 ACHE (0.44) ACHEEPHX1
SCHEMBL20299527 0.86 EPHX1 (0.63) ACHEEPHX1
SCHEMBL5248688 0.85 ACHE (0.58) ACHEEPHX1ALOX15
SCHEMBL5246644 0.84 ACHE (0.61) ACHEEPHX1ALOX15
SCHEMBL14451905 0.84 ACHE (0.85) ACHEEPHX1
SCHEMBL29335436 0.82 ACHE (0.36) ACHEEPHX1
SCHEMBL5246317 0.82 ACHE (0.54) ACHEEPHX1ALOX15
SCHEMBL5245868 0.81 ACHE (0.58) ACHEEPHX1ALOX15
SCHEMBL5244937 0.81 EPHX1 (0.47) ACHEEPHX1
SCHEMBL5247081 0.81 ACHE (0.58) ACHEEPHX1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180015120-A1 Self-assembling monomers and oligomers as surface-modifying endgroups for polymers DSM IP ASSETS BV (NL) 2018-01-18 — — US disclosed
US-20120095166-A1 SELF-ASSEMBLING MONOMERS AND OLIGOMERS AS SURFACE-MODIFYING ENDGROUPS FOR POLYMERS WARD ROBERT S (US) 2012-04-19 — — US disclosed
US-20090258048-A1 Self-Assembling Monomers and Oligomers as Surface-Modifying Endgroups for Polymers THE POLYMER TECHNOLOGY GROUP, INC. (US) 2009-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180015120-A1 Self-assembling monomers and oligomers as surface-modifying endgroups for polymers MLX, SRRM2, LIMA1 ACHE 2356/4885EPHX1 901/4885ALOX15 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback